Chiefs have pitched a child welfare reform plan that divests control from government and gives power to new First Nations led ...

Large enterprises operating across borders require governance systems that scale with complexity. This article highlights how Ashutosh Agarwal builds analytics-driven frameworks that strengthen ...

The Navy is following the U.S. Air Force, which awarded contracts to Anduril and General Atomics for the first increment of its CCAs. The Marine Corps in December also awarded Northrop Grumman and ...

Program business did not explode because of luck or timing; it grew because an underserved yet powerful corner of the market ...

Partner program empowers advisors, consultants, and technology partners to work together under a global framework built ...

With HuginCore and zone controllers, Volvo is taking the step towards software-defined vehicles. OTA allows the EX60 to continuously learn and improve.

Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its experimental pill to market.

TRAVERSE CITY — Grand Traverse County commissioners want answers about the Chain of Lakes and the work that’s needed on the dams that control their levels. So they voted unanimously this week to seek ...

The Pentagon is looking to launch a new Enterprise Command and Control Program Office in a move that would consolidate and refresh its long-standing efforts to provide common operating panes and ...

TALLAHASSEE, Fla. (WCTV) - College football looks more like its big brother the NFL with each passing season, now with the advent of contracts and direct compensation it’s closer than ever, after a ...

Good day, and thank you for standing by. Welcome to the Structure Therapeutics top line results from the aleniglipron Phase II Access Program. [Operator Instructions] Please be advised that today's ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...